Sensitivity analyses to account for losses to follow-up in the antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

被引：0
|
作者：
Davis, BR [1 ]
Ford, C [1 ]
Pressel, S [1 ]
Dunn, K [1 ]
Piller, L [1 ]
机构：
[1] Univ Texas, Sch Publ Hlth, Houston, TX USA
来源：
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
68
引用
收藏
页码：76S / 76S
页数：1
相关论文
共 50 条
  • [41] Heart failure with preserved and impaired left ventricular systolic function in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, Barry R.
    Simpson, Lara M.
    Black, Henry R.
    Cushman, Wililam C.
    Einhorn, Paula T.
    Farber, Michael A.
    Ford, Charles E.
    Levy, Daniel
    Massie, Barry M.
    Nawaz, Shah
    Nawaz, Shah
    CIRCULATION, 2006, 114 (18) : 571 - 571
  • [42] THE EFFECT OF RENAL FUNCTION ON INCIDENCE OF CONGESTIVE HEART FAILURE: THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) STUDY
    Kholghi, Maedeh Khayyat
    Oparil, Suzanne
    Davis, Barry
    Tereshchenko, Larisa G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 752 - 752
  • [43] Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Alderman, Michael H.
    Piller, Linda B.
    Ford, Charles E.
    Probstfield, Jeffrey L.
    Oparil, Suzanne
    Cushman, William C.
    Einhorn, Paula T.
    Franklin, Stanley S.
    Papademetriou, Vasilios
    Ong, Stephen T.
    Eckfeldt, John H.
    Furberg, Curt D.
    Calhoun, David A.
    Davis, Barry R.
    HYPERTENSION, 2012, 59 (05) : 926 - +
  • [44] The relation of hypokalemia at 1 year to morbidity and mortality: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) experience
    Alderman, M.
    Piller, L.
    Ford, C.
    Davis, B.
    Einhorn, P.
    Cushman, W.
    Calhoun, D.
    Eckfeldt, J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 671 - 671
  • [45] Relationship of 1 year hypokalemia incidence to clinical outcomes in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Alderman, Michael
    Calhoun, David
    Cushman, William
    Davis, Barry
    Eckfeldt, John
    Einhorn, Paula
    Ford, Charles
    Franklin, Stanley
    Furberg, Curt
    Ong, Stephen
    Oparil, Suzanne
    Papademetriou, Vasilios
    Piller, Linda
    Probstfield, Jeffrey
    CIRCULATION, 2006, 114 (18) : 576 - 576
  • [46] Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Grimm, RH
    Margolis, KL
    Papademetriou, V
    Cushman, WC
    Ford, CE
    Bettencourt, J
    Alderman, MH
    Basile, JN
    Black, HR
    DeQuattro, V
    Eckfeldt, J
    Hawkins, CM
    Perry, HM
    Proschan, M
    HYPERTENSION, 2001, 37 (01) : 19 - 27
  • [47] Response to letter regarding article, "Role of diuretics in the prevention of heart failure: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)"
    Davis, Barry R.
    Piller, Linda B.
    Dunn, Kay
    CIRCULATION, 2007, 115 (02) : E19 - E19
  • [48] Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome - Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Wright, Jackson T.
    Harris-Haywood, Sonja
    Pressel, Sara
    Barzilay, Joshua
    Bairnbridge, Charles
    Bareis, Charles J.
    Basile, Jan N.
    Black, Henry R.
    Dart, Richard
    Gupta, Alok K.
    Hamilton, Bruce P.
    Einhorn, Paula T.
    Haywood, L. Julian
    Jafri, Syed Z. A.
    Louis, Gail T.
    Whelton, Paul K.
    Scott, Cranford L.
    Sinnnons, Debra L.
    Stanford, Carol
    Davis, Barry R.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (02) : 207 - 217
  • [49] TOWARD IDENTIFYING PERSONALIZED PROGNOSIS IN HYPERTENSION: VARIATION IN EARLY RESPONSES IN THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT)
    Dhruva, Sanket Shishir
    Huang, Chenxi
    Spatz, Erica
    Coppi, Andreas
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Xu, Xiao
    Furberg, Curt
    Davis, Barry
    Pressel, Sara
    Coifman, Ronald
    Krumholz, Harlan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1762 - 1762
  • [50] Clinical implications of recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and other studies of hypertension
    Furberg, CD
    Psaty, BM
    Pahor, M
    Alderman, MH
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (12) : 1074 - 1078
12345